Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Case Number:
1:22-cv-00252
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 10, 2023
Judge Not Convinced By DOJ's 'Say-So' In Vax IP Row
Deciding that it wasn't going to be immediately swayed by "the government's say-so," a Delaware federal court on Friday quickly turned down the Biden administration's efforts to subsume liability for part of a billion-dollar patent dispute over the ownership of the mRNA platform used in Moderna's COVID-19 vaccines.
-
March 08, 2023
Moderna Tries To Kick Ex-Judge Out Of COVID Vax IP Row
Moderna has responded to arguments from a former top federal judge, among other legal academics and pharmaceutical trade organizations that are weighing in on a billion-dollar patent lawsuit over the ownership of the mRNA platform behind one of the COVID-19 vaccines, by asking a federal judge in Delaware to disregard those arguments entirely.
-
March 03, 2023
Ex-Judges Worried About Where COVID Vax IP Row Will Go
The Biden administration's position that the government should be the target of a billion-dollar patent suit over Moderna's COVID-19 vaccine in federal claims court has been decried by that court's former top judge and other officials, who say that approach flouts patent law.
-
February 14, 2023
Moderna Is Wrong Target Of COVID Vax IP Claims, Feds Say
The U.S. government urged a Delaware federal judge on Tuesday to toss claims accusing Moderna Inc. of infringing the patents of a rival mRNA developer with its COVID-19 vaccine, saying that because the vaccine was developed for the government, the claims can only target the government.
-
November 02, 2022
Moderna Loses Bid To Punt COVID Vax Patent Suit To Gov't
Moderna Inc. must continue to fight claims that it infringed the patents of a rival mRNA developer with its COVID-19 vaccine, a Delaware federal judge ruled Wednesday in finding Moderna can't yet establish that the vaccine was developed specifically "for the government," thus shielding it from the litigation.
-
June 06, 2022
Moderna Can't Punt To Gov't In COVID-19 Vax Suit, Cos. Say
Two companies suing Moderna Inc. in Delaware federal court for patent infringement over its widely used COVID-19 vaccine have slammed the drugmaker's attempt to toss part of the case, saying the government cannot act as a shield from paying damages.
-
May 06, 2022
Moderna Says COVID-19 Vax Patent Suit Should Be Tossed
Moderna Inc. on Friday urged a Delaware federal court to throw out a lawsuit accusing it of infringing the patents of a rival mRNA developer with its COVID-19 vaccine, arguing that the claims should be filed against the federal government, not Moderna.
-
February 28, 2022
Moderna Faces Patent Suit Over Its COVID-19 Vaccine
Moderna was hit with a suit on Monday that accused it of earning "billions in profits" by selling COVID-19 vaccines that infringed the patents of a rival mRNA developer.